# Relmada Therapeutics, Inc.: Form 8-K, filed Feb 5, 2018

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2018-02-05
- Accepted by EDGAR: Feb 5, 2018, 16:59 ET
- Period: 2018-02-02
- Accession: 0001213900-18-001309
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390018001309/f8k020218_relmadathera.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390018001309/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390018001309/f8k020218_relmadathera.htm

Filed Feb 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001213900-18-001309. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
